Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.75
Bid: 13.50
Ask: 14.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.704%)
Open: 13.75
High: 13.75
Low: 13.75
Prev. Close: 13.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Randgold, Goldstone Fall As Drilling Results Disappoint

Tue, 18th Feb 2014 11:50

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.

-------

FTSE 100 - WINNERS

BHP Billiton, up 1.2%. The Anglo-Australian mining giant has reported an 83% increase in profit for the first half of fiscal 2014, aided by its cost-cutting measures that helped offset the impact of lower commodity prices. It said profit for the half-year to December 31 was USD8.11 billion, up from USD4.43 billion in the year-earlier period. The company's underlying earnings before interest, tax, depreciation and amortization rose 16% from the year-ago period to USD16.52 billion. BHP also increased its interim dividend by 3.5%.

IMI, up 0.7%. The company has followed up Monday's share consolidation with the return of cash to shareholders through payment of a C share dividend and redemption of B shares. The moves are a result of its decision to return GBP620 million in cash to shareholders from the proceeds of the sale of its beverage dispensing business.

-------

FTSE 100 - LOSERS

InterContinental Hotels, down 3.7%. Despite reporting positive 2013 results, shares are lower on concerns of a tougher 2014. The owner of hotel brands including Crowne Plaza, Holiday Inn, and Intercontinental Hotels & Resorts, reported a pretax profit of USD600 million for the year, up from USD547 million in 2012, as revenues rose to USD1.90 billion, from USD1.84 billion. Analysts at Investec say that 2014 is "shaping up as a high capex year", after the company guided that capital expenditure will be 20% ahead of previous forecasts. Investec has put its forecasts under review as it worries about what impact hotel refurbishments will have on room closures, as well as the associated delay in further cash returns.

Centrica, down 2.7%. UBS has downgraded the company to Sell, from Neutral, cutting its price target to 280.00 pence from 340.00p. UBS believes that UK Energy Secretary Ed Davey's recent letter to regulators highlighting areas of energy market concern, in which British Gas' gas retail margin and large market share was the primary focus, leaves Centrica facing risks from both the opposition Labour party and the coalition government.

Randgold Resources, down 1.7%. AIM All-Share-constituent Goldstone Resources has announced that test results from drilling on the Baraboye and Ibel prospects at its Sangola joint venture project in Senegal, which it shares with Randgold, has not returned gold intercepts that justify an immediate follow-up programme.

-------

FTSE 250 - WINNERS

Bwin.party digital entertainment, up 5.2%. The group has seen its share price jump Tuesday after a US investment manager late Monday said that it has agreed in principle to acquire a stake of about 6.1% in the online gaming company from its founders. SpringOwl Gibraltar Partners B Ltd said it has agreed to buy just over 49.8 million bwin.party shares from Emerald Bay Ltd and Stinson Ridge Ltd, funds owned by the company's founders.

John Wood Group, up 4.1%. The oil services company said it has performed well in 2013, with strong pretax profit driven by higher revenues and margins. Its pretax profit increased 14% to USD412.8 million, from USD361.4 million in 2012, although that was slightly below the USD424 million analysts had been expecting. Revenues increased 3% to USD7.06 billion, from USD6.83 billion in 2012, with an 11% revenue increase at its engineering division and a 8.3% revenue increase at its PSN division significantly offsetting a 19% fall in revenues from its GTS division.

Bank of Georgia Holdings, up 3.9%. The group has reported record earnings for 2013. The bank said it made a GEL245.3 million pretax profit, compared with GEL212.8 million in 2012, buoyed by net interest income and net insurance revenue growth. Overall revenue grew by 9.5% to GEL545.5 million. Moreover, with the macro economy looking positive, a combination of a dominant market position, strong GDP growth, low levels of debt to GDP, and high return on equity, "make for an ideal backdrop for Bank of Georgia," says Numis analyst James Hamilton.

Paragon Group of Companies, up 3%. The consumer finance lender and buy-to-let mortgage provider has now launched its new challenger bank, making good on previous guidance that the new bank would get regulatory approval inside the second-quarter. The group will provide Paragon Bank with an initial GBP12.7 million in capital and will inject more over time in order to support growth.

-------

FTSE 250 - LOSERS

Drax Group, down 2.9%. The UK energy provider said its pretax profit fell significantly during 2013 as expected increased costs offset positive revenues. It said pretax profit fell 83% to GBP31.8 million, down from GBP190.2 million in 2012, blaming the loss predominantly on increased carbon costs. Although Liberum Capital said the company's 2013 results beat its estimates, it said that it now expects the firm to experience tougher conditions in 2014.

Unite Group, down 1.8%. The student accommodation provider has acquired a 1.8 acre development site on St Leonard's Street in Edinburgh, subject to planning and funding agreements, for an undisclosed fee.

-------

AIM - WINNERS

Probability, up 49%. The group said it is to be acquired by GTECH UK Interactive Ltd in a deal valuing the company at GBP18.0 million. Shares have jumped to 47.01 pence in the wake of the news, with shareholders set to receive 50 pence a share under the terms of the recommended cash acquisition. The deal means shareholders will receive a 59% premium on Monday's closing price of 31.5 pence.

Clean Air Power, up 8.7%. The company said it has received an order for 19 Genesis-EDGE Dual Fuel trucks from an unnamed distribution company in the UK in a deal worth GBP500,000.

Dekeloil, up 7.9%. The company said oil production at its CPO extraction mill in the Ivory coast has commenced ahead of schedule. It said construction was completed ahead of schedule and on budget by Malaysian company Modipalm Engineering SDN BHD and following successful testing, commercial production began.

Providence Resources, up 6.8%. Providence Resources said that the licence area at its 80% owned Barryroe Oil Field has been increased after it was granted a 180 square kilometre increase in the extent of the standard exploration licence 1/11, which contains the site.

Keywords Studios, up 6.7%. The firm has acquired Babel Media for GBP5.4 million in both cash and shares, as it steps up its growth strategy to add client numbers and penetrate markets. Keywords said it will pay Babel GBP2.2 million in shares, with the remaining GBP3.2 million being used to pay off Babel's debts.

ANGLE PLC, up 6.5%. The specialist med-tech company said it will launch its Parsortix non-invasive cancer diagnostic system at a science and medical researcher conference in Berlin on Wednesday. ANGLE's Parsortix system enables the capture of circulating tumour cells from cancer patient blood for mutational analysis, using a simple blood test to capture the cancer cells for analysis.

-------

AIM - LOSERS

Goldstone Resources, off 15%. The company's share price has dropped after it said results from drilling on two sites at its Sangola joint venture project were not enough to warrant a follow-up programme.

-------

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
22 Apr 2024 16:52

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells.

Read more
22 Apr 2024 06:59

Angle granted European patent for CellKeep, US patent imminent

(Sharecast News) - Liquid biopsy specialist Angle announced on Monday that it has received a European patent for its 'CellKeep' slide, as it anticipated the imminent grant of an equivalent US patent application.

Read more
22 Jan 2024 18:03

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Read more
4 Jan 2024 16:54

LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls

(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data.

Read more
4 Jan 2024 12:19

Angle shares soar following "breakthrough" cancer diagnostics results

(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services.

Read more
4 Jan 2024 12:09

LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100

(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak it suffered at the start of the year.

Read more
4 Jan 2024 10:43

AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
4 Jan 2024 08:58

LONDON MARKET OPEN: Next leads buoyant FTSE 100 amid services PMIs

(Alliance News) - Stock prices in London opened up on Thursday, amid a slew of services PMI data, including for the UK, while reacting to the latest data from China.

Read more
4 Jan 2024 07:58

Angle receives 'breakthrough results' from DNA molecular analysis

(Sharecast News) - Liquid biopsy company Angle received "breakthrough results" from DNA molecular analysis of cancer patient blood samples on Thursday, sending its shares skywards as a result.

Read more
2 Jan 2024 09:04

Angle locks in $250,000 contract with Eisai

(Sharecast News) - Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumour cell analysis in a pilot study.

Read more
2 Jan 2024 08:51

IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial

Angle PLC - Surrey, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co Ltd. Under the agreement, the two will engage in a pilot study worth USD250,000 to Angle. Angle will provide circulating-tumour-cells analysis using its Portrait HER2 assay to assess the response of breast cancer patients to Eisai's BB-1701 antibody-drug conjugate. BB-1701 targets HER2, a protein that speeds up the growth of breast cancer cells. Success in the phase two pilot study will offer the possibility for multiple follow-up studies.

Read more
11 Dec 2023 20:44

TRADING UPDATES: Ondine Biomedical raises GBP2.9 million via placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2023 11:50

IN BRIEF: Angle launches diagnostic kit at cancer symposium

Angle PLC - Surrey, England-based medical diagnostics company - Launches its Portrait Plus CTC staining kit at the San Antonio Breast Cancer Symposium, following "extensive" development, optimisation and validation of the kit. Explains that the kit is read-to-use, and designed for the dentification, characterisation and enumeration of epithelial and mesenchymal cancer cells. This includes those undergoing epithelial-to-mesenchymal transition.

Read more
9 Nov 2023 14:29

Angle says build up of revenue slower than hoped; launches test

(Alliance News) - Angle PLC on Thursday said it expects revenue in 2023 to more than double from 2022 as it announced the launch of a new test aimed to support cancer therapy studies.

Read more
25 Oct 2023 17:28

TRADING UPDATES: Franchise Brands trading in line; Tribe secures loan

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.